24.12.18|Lilach BaumerThe investment is part of a licensing option agreement signed between the two companies
16.01.18|Zohar Shahar LevyZelig Eshhar, the patent holder for Kite Pharma’s anti-cancer technology, is currently being sued by a former student for infringement of patent rights
21.11.17|Lilach BaumerThe Novartis-backed company is developing a universal bone marrow transplant solution for patients unable to find a donor
19.10.17|Lilach BaumerThe cancer-treatment company, bought by Gilead Science in August for $11.9 billion, will sell one treatment course of the drug for $373,000